Timeline
hVIVO
hVIVO orderbook more than doubles to £65m
hVIVO signs consultancy deal with Decoy Therapeutics to advance multi‑virus antivirals
hVIVO still has work to do to prove its recovery says analyst
hVIVO to run pivotal Phase III whooping cough human challenge trial for ILiAD
hVIVO revenue slides, strategy pivot offsets market hit
hVIVO inks influenza human challenge trial with Traws Pharma
hVIVO reunifies brands into single end-to-end clinical development platform
More in Healthcare Services
GENinCode genetic test cuts cardiac risk in Catalonia pilot
A real-world pilot by Catalonia's health service found GENinCode's CARDIO inCode-Score reclassified risk in over 40% of moderate-risk patients and drove measurable improvements in cholesterol and smoking cessation.